APLM Apollomics Inc.

Nasdaq N/A


$ 15.04 $ -3.13 (-17.51 %)    

Thursday, 20-Nov-2025 15:46:12 EST
QQQ $ 586.37 $ -14.20 (-2.37 %)
DIA $ 458.49 $ -3.66 (-0.79 %)
SPY $ 653.38 $ -10.10 (-1.52 %)
TLT $ 89.28 $ 0.35 (0.39 %)
GLD $ 374.81 $ -0.11 (-0.03 %)
$ 14.75
$ 17.68
$ 14.50 x 137
$ 15.00 x 967
$ 15.12 - $ 18.00
$ 3.66 - $ 42.12
29,595
na
16.27M
$ 0.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 apollomics-enters-into-settlement-agreement-with-twvc-goldlink-partners-investment-and-twvc-panglin-group-investment-to-pay-5m-in-cash-and-87975778-in-associated-legal-expenses

-SEC Filing

 apollomics-receives-39m-payment-from-launxp-maintains-active-collaboration-on-vebreltinib-development

Pursuant to the Company's Form 6-K filed on July 25, 2025 (the "July 2025 6-K"), Apollomics Inc. ("Apollomics&#...

 nasdaq-cancels-delisting-hearing-for-apollomics-confirms-compliance-with-continued-listing-standards

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a California based late-stage clinical biopharma...

Core News & Articles

The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading will resume in Apollomics Inc. Class A ordinary shares (NASDAQ:AP...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION